Assenagon Asset Management S.A. Sells 203,371 Shares of The Cooper Companies, Inc. $COO

Assenagon Asset Management S.A. lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 75.0% in the first quarter, Holdings Channel reports. The institutional investor owned 67,934 shares of the medical device company’s stock after selling 203,371 shares during the period. Assenagon Asset Management S.A.’s holdings in Cooper Companies were worth $4,857,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after acquiring an additional 7,363 shares in the last quarter. First Trust Advisors LP lifted its position in Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after acquiring an additional 73,165 shares in the last quarter. Cresset Asset Management LLC purchased a new stake in Cooper Companies during the 2nd quarter valued at $291,000. Cerity Partners LLC increased its holdings in shares of Cooper Companies by 4.4% in the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after purchasing an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in shares of Cooper Companies by 2.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after purchasing an additional 973 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Up 0.5%

COO opened at $71.39 on Tuesday. The firm’s 50 day simple moving average is $64.14 and its two-hundred day simple moving average is $73.56. The company has a market capitalization of $13.92 billion, a PE ratio of 60.50, a PEG ratio of 1.86 and a beta of 0.88. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Citigroup reaffirmed a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Barclays boosted their target price on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. Finally, Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, Cooper Companies currently has a consensus rating of “Hold” and a consensus price target of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.